| Literature DB >> 32076586 |
Ya-Ching Hsieh1, Harsh R Shah2, Pradeep Balasubramaniam3.
Abstract
BACKGROUND: In obstetrical health care, disparities have been documented in different aspects of maternal care and outcomes. Prior epidemiological studies have shown that labor analgesia is underused in African-American and Hispanic groups, which means there may be inadequate labor pain control in these groups. Differences in usage have been attributed primarily to insurance, educational levels and perceptional influences such as fear of paralysis and chronic low back pain. In cesarean section deliveries, race and ethnicity affect the choice of anesthesia considered. How race and ethnicity affect maternal outcomes in cesarean sections with epidural placements generally has been unexplored. Disparities in health care utilization are shown to contribute to the disparities in health outcomes.Entities:
Keywords: cesarean; epidural anesthesia; ethnicity; nationwide inpatient sample; nis; obstetrics; outcomes; population based research; race; racial disparity
Year: 2020 PMID: 32076586 PMCID: PMC7015115 DOI: 10.7759/cureus.6652
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Univariate analysis of the epidemiological characteristics of women who have undergone a cesarean section with epidural anesthesia
Percentages in brackets are column % that indicate the direct comparison of racial disparity among women who have undergone a cesarean section with epidural anesthesia.
p-values were calculated based on racial groups: Caucasian, African American, Hispanic, Asian, and Native American.
| Total (n=87,076) | Caucasian (n=55,098) | African American (n=11,649) | Hispanic (n=16,977) | Asian (n=2,515) | Native American (n=837) | p-values | |||
| SOCIODEMOGRAPHICS | |||||||||
| Age group (year) | <0.0001 | ||||||||
| 18-34 | 71,109 | 46,066 (85) | 9,308 (84) | 13,133 (80) | 1,911 (77) | 691 (85) | |||
| 35-49 | 13,565 | 7,822 (15) | 1,824 (16) | 3,230 (20) | 567 (23) | 122 (15) | |||
| 50-64 | 15 | <10 (0) | <10 (0) | 0 (0) | <10 (0) | 0 (0) | |||
| Insurance | <0.0001 | ||||||||
| Medicare/ Medicaid | 38,722 | 18,125 (33) | 7,797 (67) | 11,630 (69) | 699 (28) | 471 (56) | |||
| Private | 42,197 | 34,152 (62) | 2,646 (23) | 3,427 (20) | 1,662 (66) | 311 (37) | |||
| Other | 5,986 | 2,661 (5) | 1,196 (10) | 1,921 (11) | 154 (6) | 55 (7) | |||
| Location/Teaching Status | <0.0001 | ||||||||
| Rural | 15,347 | 12,802 (23) | 340 (3) | 1,200 (7) | 683 (27) | 322 (38) | |||
| Urban non-teaching | 23,629 | 18,795 (34) | 1,731 (15) | 2,471 (15) | 551 (22) | 80 (10) | |||
| Urban teaching | 48,100 | 23,501 (43) | 9,577 (82) | 13,307 (78) | 1,280 (51) | 435 (52) | |||
| Comorbidities | |||||||||
| Hypertension | 3,264 | 1,719 (3) | 894 (8) | 564 (3) | 51 (2) | 36 (4) | <0.0001 | ||
| Obesity | 5,050 | 3,002 (5) | 1,077 (9) | 874 (5) | 35 (1) | 62 (7) | <0.0001 | ||
| Congestive heart failure | 41 | 27 (0.1) | <10 (0.1) | 0 (0) | <10 (0.2) | 0 (0) | 0.0002 | ||
| Diabetes | 1,358 | 707 (1.28) | 288 (2.48) | 334 (1.97) | 14 (0.56) | 15 (1.79) | <0.0001 | ||
| Renal failure | 48 | 24 (0.04) | 14 (0.12) | 10 (0.06) | 0 (0) | 0 (0) | 0.014 | ||
| Coagulopathy | 1,087 | 686 (1.25) | 156 (1.34) | 210 (1.23) | 30 (1.21) | <10 (0.61) | 0.45 | ||
| ADVERSE OUTCOMES | |||||||||
| Hematoma | 110 | 46 (0.08) | 13 (0.11) | 47 (0.28) | <10 (0.17) | 0 (0) | <0.0001 | ||
| Surgical site infection | 34 | 29 (0.05) | 0 (0) | <10 (0.03) | 0 (0) | 0 (0) | 0.051 | ||
| Postpartum hemorrhage | <10 | <10 (0.01) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0.54 | ||
| Blood transfusion | 15 | 0 (0) | 5 (0.04) | 10 (0.06) | 0 (0) | 0 (0) | <0.0001 | ||
| Severe anesthesia complications | 851 | 560 (1.02) | 71 (0.61) | 171 (1.01) | 19 (0.76) | 30 (3.58) | <0.0001 | ||
| Amniotic fluid embolism | 13 | <10 (0.01) | 0 (0) | <10 (0.03) | 0 (0) | 0 (0) | 0.41 | ||
| Disseminated intravascular coagulation | 315 | 194 (0.35) | 34 (0.29) | 73 (0.43) | 14 (0.57) | 0 (0) | 0.04 | ||
| Pulmonary edema | 60 | 35 (0.06) | <10 (0.04) | 20 (0.12) | 0 (0) | 0 (0) | 0.047 | ||
| Cardiac arrest/ventricular fibrillation | 9 | <10 (0.01) | <10 (0.05) | 0 (0) | 0 (0) | 0 (0) | |||
| In-hospital Mortality | 10 | <10 (0.01) | <10 (0.05) | 0 (0) | 0 (0) | 0 (0) | 0.004 | ||
| Discharge Destination | <0.0001 | ||||||||
| Home | 83,302 | 52,246 (95) | 11,446 (98) | 16,436 (97) | 2,373 (94) | 801 (96) | |||
| Short term/ Intermediate care | 3,769 | 2,852 (5) | 203 (2) | 537 (3) | 141 (6) | 36 (4) | |||
| Total Charge | 14,604 | 12,798 | 18,559 | 17,725 | 13,683 | 15,643 | <0.0001 | ||
| Length of Stay (day) | 3.7 | 3.6 | 4.1 | 3.9 | 3.7 | 3.6 | <0.0001 | ||